A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease
NCT03936660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1049
Last updated 2024-11-21
Summary
COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention to improve the management of patients with type 2 diabetes mellitus and cardiovascular disease.
Conditions
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
Interventions
- OTHER
-
Intense Education Intervention
Clinics provided with existing clinical care guidelines as well as a multifaceted educational intervention to support development of an integrated, multi-disciplinary care pathway for patients with T2DM and CVD.
Sponsors & Collaborators
- collaborator INDUSTRY
- collaborator INDUSTRY
- lead OTHER
Principal Investigators
-
Christopher Granger, MD · Duke Clinical Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-25
- Primary Completion
- 2022-12-30
- Completion
- 2022-12-30
Countries
- United States
Study Locations
More Related Trials
-
A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382
NCT03341013 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes
NCT06938334 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes
NCT00477204 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
NCT02098395 ·Status: COMPLETED ·Phase: PHASE3
-
A Study for Patients With Type 2 Diabetes Mellitus
NCT00804986 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
NCT00791479 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus
NCT06132126 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes
NCT07112339 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
NCT03736785 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
NCT02072096 ·Status: TERMINATED ·Phase: PHASE4
-
TODAY2 Phase 2 Follow-up
NCT02310724 ·Status: COMPLETED
-
Innovative Automated Insulin Delivery System for Type 2 Diabetes
NCT06853990 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
NCT06297603 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
NCT06362265 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus
NCT00642538 ·Status: COMPLETED ·Phase: PHASE1
-
A Study for Participants With Type 2 Diabetes Mellitus
NCT00871572 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes
NCT01995656 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
NCT07215312 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes
NCT06945406 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of LY3209590 in Participants With Type 2 Diabetes
NCT03367377 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of CT-868 in Type 1 Diabetes Mellitus
NCT06062069 ·Status: COMPLETED ·Phase: PHASE2
-
Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
NCT02346344 ·Status: COMPLETED
-
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
NCT04450394 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
NCT04143802 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
NCT01836523 ·Status: COMPLETED ·Phase: PHASE3